ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

US Sues St. Luc Hospital For Grant Funds, Expenses Of Data Reanalysis, Investigation

June 9, 1995

In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35%

October 14, 1977

In Brief: Issell To Retire As Hawaii Center Director; M.D. Anderson honors LeMaistre, Faculty

November 8, 1996

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

Mayer Will Emphasize Rehab Research While Serving On NCAB

May 24, 1991